Larvol Delta - A-Phase-II-Study-of-Utidelone-With-Toripalimab-in-Advanced-Cervical-Cancer

utidelone IV (UTD1) - Beijing Biostar Technologies

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Biosci, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07363330

Jan 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next